Combining Selinexor with R-CHOP in the Treatment of Newly Diagnosed High-Risk (IPI 35) GCB Subtype DLBCL Patients: A Multicenter, Open Label Phase 2 StudyZhiming Li,Hang Yang,Yanxue Yin,Yajun Li,Xue Gao,Peng Sun,Yu Wang,Lu Zhang,Hui Zhou,Keshu Zhou,Jay MeiBLOOD(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要